Authors: Abigail Burdon, Thomas Jaki, Xijin Chen, Pavel Mozgunov, Haiyan Zheng, Richard Baird

Published on: May 10, 2024

Impact Score: 7.6

Arxiv code: Arxiv:2405.06353

Summary

• What is new: Introduction of seamless clinical trials and master protocols to streamline drug development in cancer research.
• Why this is important: Inefficiency, high costs, and lengthy processes in drug development, especially in Phase II / III cancer clinical trials.
• What the research proposes: Utilizing seamless clinical trials and master protocols to accelerate the development of promising therapies and investigate multiple treatments within a single trial.
• Results: These methods have shown success in accelerating therapy development and addressing regulatory considerations, ultimately aiming to deliver treatments to patients faster.

Technical Details

Technological frameworks used: Seamless clinical trials, Master protocols

Models used: Not specified

Data used: Real trial examples

Potential Impact

Pharmaceutical industry, specifically companies involved in oncology drug development

Want to implement this idea in a business?

We have generated a startup concept here: TrialStream.